On Feb. 28, King Pharmaceuticals (NYSE:KG) released earnings for the fourth quarter ended Dec. 31.

  • The top line grew by 21.2% due to higher sales of the Altace blood-pressure drug and the Skelaxin muscle relaxant.
  • The company expanded its THROMBIN-JMI franchise by acquiring an exclusive license to Vascular Solutions' hemostatic products, used to check bleeding.
  • King Pharmaceuticals says it will launch the new Altace tablets in the fourth quarter of 2007 or the first quarter of 2008.
  • Among Motley Fool CAPS All-Stars, 96% have an outperform rating on the company.

(Figures in millions, except per-share data)

Income Statement Highlights

Q4 2006

Q4 2005

Change

Sales

$512.9

$423.3

21.2%

Net Profit*

$37.1

($94.2)

N/A

EPS

$0.15

($0.39)

N/A

Diluted Shares

243.1

241.8

0.5%

*Income from continuing operations

Get back to basics with a look at the income statement.

Margin Checkup

Q4 2006

Q4 2005

Change*

Gross Margin

77.8%

84.1%

(6.3)

Operating Margin

8.2%

(34.9%)

43.1

Net Margin

7.2%

(22.3%)

29.5

*Expressed in percentage points

Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Assets

Q4 2006

Q4 2005

Change

Cash + ST Invest.

$1,004.0

$524.7

91.3%

Accounts Rec.

$265.5

$223.6

18.7%

Inventory

$215.5

$228.1

(5.5%)



Liabilities

Q4 2006

Q4 2005

Change

Accounts Payable

$77.2

$84.5

(8.7%)

Long-Term Debt

$400.0

$345.0

15.9



Learn the ways of the balance sheet.

Cash Flow Highlights

No data was available.

Find out why Fools always follow the money.

Related Foolishness:

Need new ideas for your money? Investors like you rate thousands of stocks on Motley Fool CAPS to help you with your own stock selections. It's fun --and it's free.

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.